APA (7th ed.) Citation

Liu, S., Wang, K., Wang, R., Chen, H., Wan, Z., Dou, L., & Li, S. Cost-effectiveness of cadonilimab plus chemotherapy in the first-line treatment of HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma. SAGE Publishing.

Chicago Style (17th ed.) Citation

Liu, Shixian, Kaixuan Wang, Ruixue Wang, Hao Chen, Ziming Wan, Lei Dou, and Shunping Li. Cost-effectiveness of Cadonilimab Plus Chemotherapy in the First-line Treatment of HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. SAGE Publishing.

MLA (9th ed.) Citation

Liu, Shixian, et al. Cost-effectiveness of Cadonilimab Plus Chemotherapy in the First-line Treatment of HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. SAGE Publishing.